$SLS
SELLAS Life Sciences Group, Inc. Stock $sls

$sls Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-Q Financial Statement

#000139047819000056 Filed on November 14, 2019

Income Statement

Concept	2019 Q4	2019 Q3	2018 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.400M	$2.385M	$1.341M
YoY Change	-9.09%	77.85%	-58.38%
% of Gross Profit
Research & Development	$2.250M	$1.799M	$1.720M
YoY Change	-38.36%	4.59%	61.05%
% of Gross Profit
Depreciation & Amortization			$0.00
YoY Change			-100.0%
% of Gross Profit
Operating Expenses	$4.650M	$4.184M	$3.061M
YoY Change	-26.07%	36.69%	-28.65%
Operating Profit
YoY Change
Interest Expense	$30.00K	$60.00K	-$70.00K
YoY Change	0.0%	-185.71%	-30.0%
% of Operating Profit
Other Income/Expense, Net	-$50.00K	-$4.202M	-$290.0K
YoY Change	-105.26%	1348.97%	-93.4%
Pretax Income	-$7.500M	-$4.200M	-$290.0K
YoY Change	-49.53%	1348.28%	-93.39%
Income Tax	-$80.00K	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$7.420M	-$4.202M	-$290.0K
YoY Change	-44.29%	1348.97%	-93.49%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.539M	-$981.3K	-$828.6K
COMMON SHARES
Basic Shares Outstanding	4.872M shares	226.5M shares	19.57M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q4	2019 Q3	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.300M	$9.100M	$10.00M
YoY Change	37.74%	-9.0%	-22.48%
Cash & Equivalents	$7.277M	$9.119M	$10.00M
Short-Term Investments
Other Short-Term Assets	$700.0K	$1.100M	$1.300M
YoY Change	40.0%	-15.38%	-90.51%
Inventory
Prepaid Expenses
Receivables
Other Receivables			$6.600M
Total Short-Term Assets	$8.242M	$10.21M	$17.81M
YoY Change	41.18%	-42.66%	-33.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$200.0K	$300.0K
YoY Change
Goodwill	$1.900M	$1.914M	$1.914M
YoY Change	0.0%	0.0%	-64.46%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$500.0K	$600.0K	$1.100M
YoY Change	-28.57%	-45.45%	1000.0%
Total Long-Term Assets	$8.367M	$11.27M	$20.66M
YoY Change	-24.47%	-45.44%	-10.0%
TOTAL ASSETS
Total Short-Term Assets	$8.242M	$10.21M	$17.81M
Total Long-Term Assets	$8.367M	$11.27M	$20.66M
Total Assets	$16.61M	$21.48M	$38.47M
YoY Change	-1.81%	-44.15%	-22.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.902M	$3.764M	$7.238M
YoY Change	3.91%	-48.0%	3330.33%
Accrued Expenses	$1.171M	$1.504M	$4.683M
YoY Change	-47.23%	-67.88%	46.99%
Deferred Revenue	$0.00
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$76.00K
YoY Change			-99.38%
Total Short-Term Liabilities	$5.290M	$5.574M	$12.00M
YoY Change	-11.45%	-53.54%	-57.19%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.000M	$4.900M	$6.300M
YoY Change	-5.66%	-22.22%	384.62%
Total Long-Term Liabilities	$5.000M	$4.900M	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.290M	$5.574M	$12.00M
Total Long-Term Liabilities	$5.000M	$4.900M	$0.00
Total Liabilities	$10.52M	$10.85M	$20.01M
YoY Change	-9.89%	-45.8%	-42.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$101.1M	-$93.73M	-$68.53M
YoY Change	23.57%	36.77%	-79.18%
Common Stock	$107.2M	$104.4M	$86.99M
YoY Change	23.12%	19.97%	-74.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.093M	$10.64M	$18.46M
YoY Change
Total Liabilities & Shareholders Equity	$16.61M	$21.48M	$38.47M
YoY Change	-1.81%	-44.15%	-22.43%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2018 Q3
OPERATING ACTIVITIES
Net Income	-$7.420M	-$4.202M	-$290.0K
YoY Change	-44.29%	1348.97%	-93.49%
Depreciation, Depletion And Amortization			$0.00
YoY Change			-100.0%
Cash From Operating Activities	-$4.170M	-$3.820M	-$14.17M
YoY Change	-8.35%	-73.04%	490.42%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.320M	190.0K	14.25M
YoY Change	-3000.0%	-98.67%	-142600.0%
NET CHANGE
Cash From Operating Activities	-4.170M	-3.820M	-14.17M
Cash From Investing Activities
Cash From Financing Activities	2.320M	190.0K	14.25M
Net Change In Cash	-1.850M	-3.630M	80.00K
YoY Change	-60.04%	-4637.5%	-103.32%
FREE CASH FLOW
Cash From Operating Activities	-$4.170M	-$3.820M	-$14.17M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q3	gale	Loss On Settlement Of Warrants Liability LossOnSettlementOfWarrantsLiability	0	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001390478
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4871927	shares
	gale	Increase Decrease In Fair Value Of Warrant Liability IncreaseDecreaseInFairValueOfWarrantLiability	491000	USD
	gale	Class Of Warrant Or Right Number Of Warrants Exercised ClassOfWarrantOrRightNumberOfWarrantsExercised	3590000	shares
	gale	Class Of Warrant Or Right Number Of Warrants Issued ClassOfWarrantOrRightNumberOfWarrantsIssued	3536000	shares
	gale	Classof Warrantor Right Canceled Or Expired ClassofWarrantorRightCanceledOrExpired	0	shares
	gale	Increase Decrease In Fair Value Of Warrant Liability IncreaseDecreaseInFairValueOfWarrantLiability	243000	USD
	gale	Longterm Debt Issued In Connection With Warrant Exchanges LongtermDebtIssuedInConnectionWithWarrantExchanges	966000	USD
	gale	Longterm Debt Issued In Connection With Warrant Exchanges LongtermDebtIssuedInConnectionWithWarrantExchanges	0	USD
	gale	Stock Issued During Period Value Pre Funded Warrant StockIssuedDuringPeriodValuePreFundedWarrant	8000	USD
	gale	Warrant Exchange Agreements Amount WarrantExchangeAgreementsAmount	285000	USD
	gale	Loss On Settlement Of Liability Classified Warrants LossOnSettlementOfLiabilityClassifiedWarrants	727000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	182000	USD
	gale	Loss On Settlement Of Liability Classified Warrants LossOnSettlementOfLiabilityClassifiedWarrants	0	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-715000	USD
	gale	Loss On Settlement Of Warrants Liability LossOnSettlementOfWarrantsLiability	727000	USD
	gale	Loss On Settlement Of Warrants Liability LossOnSettlementOfWarrantsLiability	0	USD
	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	474000	USD
	gale	Noncash Offering Expense NoncashOfferingExpense	0	USD
	gale	Noncash Offering Expense NoncashOfferingExpense	236000	USD
	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	0	USD
CY2019Q2	gale	Classof Warrantor Right Exercise Priceof Warrantsor Rights Prefunded ClassofWarrantorRightExercisePriceofWarrantsorRightsPrefunded	0.005
CY2017Q4	gale	Classof Warrantor Right Term ClassofWarrantorRightTerm	P5Y
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	gale	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	1108000	USD
CY2019Q3	gale	Closing Price Of Common Stock ClosingPriceOfCommonStock	6
CY2019Q3	gale	Common Stock Capital Shares Reserved For Future Issuance Of Employee Stock Purchase Plan CommonStockCapitalSharesReservedForFutureIssuanceOfEmployeeStockPurchasePlan	5000	shares
CY2018Q4	gale	Contingent Purchase Price Consideration Net Of Current Portion ContingentPurchasePriceConsiderationNetOfCurrentPortion	4326000	USD
CY2019Q3	gale	Contingent Purchase Price Consideration Net Of Current Portion ContingentPurchasePriceConsiderationNetOfCurrentPortion	4836000	USD
CY2018Q4	gale	Contract Research Payable ContractResearchPayable	858000	USD
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SELLAS Life Sciences Group, Inc.
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
	gale	Change In Fair Value Of Common Stock Warrants Issued In Connection With Various Equity Financings ChangeInFairValueOfCommonStockWarrantsIssuedInConnectionWithVariousEquityFinancings	5340000	USD
	gale	Change In Fair Value Of Common Stock Warrants Issued In Connection With Various Equity Financings ChangeInFairValueOfCommonStockWarrantsIssuedInConnectionWithVariousEquityFinancings	1108000	USD
	gale	Change In Fair Value Of Contingent Purchase Consideration ChangeInFairValueOfContingentPurchaseConsideration	-4025000	USD
	gale	Change In Fair Value Of Contingent Purchase Consideration ChangeInFairValueOfContingentPurchaseConsideration	-510000	USD
CY2018Q3	gale	Change In Fair Value Of Contingent Purchase Price Consideration ChangeInFairValueOfContingentPurchasePriceConsideration	-162000	USD
	gale	Change In Fair Value Of Contingent Purchase Price Consideration ChangeInFairValueOfContingentPurchasePriceConsideration	-4025000	USD
CY2019Q3	gale	Change In Fair Value Of Contingent Purchase Price Consideration ChangeInFairValueOfContingentPurchasePriceConsideration	-28000	USD
	gale	Change In Fair Value Of Contingent Purchase Price Consideration ChangeInFairValueOfContingentPurchasePriceConsideration	-510000	USD
CY2019Q3	gale	Contract Research Payable ContractResearchPayable	441000	USD
CY2018Q3	gale	Convertible Preferred Stock Dividends ConvertiblePreferredStockDividends	470000	USD
	gale	Convertible Preferred Stock Dividends ConvertiblePreferredStockDividends	487000	USD
CY2018Q3	gale	Dividend Arising From Warrant Modifications DividendArisingFromWarrantModifications	491000	USD
	gale	Dividend Arising From Warrant Modifications DividendArisingFromWarrantModifications	491000	USD
CY2019Q3	gale	Dividend Arising From Warrant Modifications DividendArisingFromWarrantModifications	7268000	USD
	gale	Dividend Arising From Warrant Modifications DividendArisingFromWarrantModifications	8659000	USD
	gale	Dividend Modification Of Warrants DividendModificationOfWarrants	491000	USD
	gale	Dividend Modification Of Warrants DividendModificationOfWarrants	243000	USD
	gale	Dividend On Conversion Of Series A Convertible Preferred Stock DividendOnConversionOfSeriesAConvertiblePreferredStock	4436000	USD
CY2018Q3	gale	Dividend On Conversion Of Series A Convertible Preferred Stock Most Favored Nation DividendOnConversionOfSeriesAConvertiblePreferredStockMostFavoredNation	-8654000	USD
	gale	Dividend On Conversion Of Series A Convertible Preferred Stock Most Favored Nation DividendOnConversionOfSeriesAConvertiblePreferredStockMostFavoredNation	-8654000	USD
	gale	Employee Service Share Based Compensation Unrecognized Compensation Costs EmployeeServiceShareBasedCompensationUnrecognizedCompensationCosts	1100000	USD
	gale	Employee Service Share Based Compensation Unrecognized Compensation Costs Weighted Average Period Of Recognition EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsWeightedAveragePeriodOfRecognition	P2Y6M10D
	gale	Fair Value Of Warrants Canceled FairValueOfWarrantsCanceled	68000	USD
	gale	Fair Value Of Warrants Exercise Price Adjustment FairValueOfWarrantsExercisePriceAdjustment	243000	USD
	gale	Fair Value Of Warrants Issued In Connection With Common Stock Recorded As Cost Of Equity FairValueOfWarrantsIssuedInConnectionWithCommonStockRecordedAsCostOfEquity	5039000	USD
	gale	Fair Value Of Warrants Issued In Connection With Common Stock Recorded As Cost Of Equity FairValueOfWarrantsIssuedInConnectionWithCommonStockRecordedAsCostOfEquity	0	USD
CY2018Q4	gale	Fair Value Of Warrants Liabilities FairValueOfWarrantsLiabilities	1013000	USD
CY2019Q3	gale	Fair Value Of Warrants Liabilities FairValueOfWarrantsLiabilities	80000	USD
CY2018Q4	gale	Fair Value Of Warrants Potentially Settleable In Cash FairValueOfWarrantsPotentiallySettleableInCash	1013000	USD
CY2019Q3	gale	Fair Value Of Warrants Potentially Settleable In Cash FairValueOfWarrantsPotentiallySettleableInCash	80000	USD
	gale	Fair Valueof Warrants Granted FairValueofWarrantsGranted	0	USD
CY2018Q4	gale	In Process Research Development InProcessResearchDevelopment	8500000	USD
	gale	Operating Lease Remaining Lease Term OperatingLeaseRemainingLeaseTerm	P1Y0M0D
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	6600000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	538000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	480000	USD
	gale	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	200000	USD
CY2019Q3	gale	Loss On Settlement Of Warrants Liability LossOnSettlementOfWarrantsLiability	0	USD
CY2019Q3	gale	In Process Research Development InProcessResearchDevelopment	8500000	USD
CY2019Q3	gale	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	100000	USD
CY2019Q3	gale	Options Reserved For Future Issuance Under Companies Incentive Plan OptionsReservedForFutureIssuanceUnderCompaniesIncentivePlan	201000	shares
CY2018Q4	gale	Prepaid Professional Services PrepaidProfessionalServices	56000	USD
CY2019Q3	gale	Prepaid Professional Services PrepaidProfessionalServices	107000	USD
	gale	Stock Issued During Period Value New Issues Repayment Of Debt StockIssuedDuringPeriodValueNewIssuesRepaymentOfDebt	2896000	USD
CY2018Q4	gale	Prepaid Research And Development PrepaidResearchAndDevelopment	48000	USD
CY2019Q3	gale	Prepaid Research And Development PrepaidResearchAndDevelopment	347000	USD
CY2018Q4	gale	Rebates And Returns Of Former Commercial Products RebatesAndReturnsOfFormerCommercialProducts	138000	USD
CY2019Q3	gale	Rebates And Returns Of Former Commercial Products RebatesAndReturnsOfFormerCommercialProducts	0	USD
	gale	Reclassification Of Warrant Liabilities Upon Exchange For Shares Of Common Stock ReclassificationOfWarrantLiabilitiesUponExchangeForSharesOfCommonStock	285000	USD
	gale	Reclassification Of Warrant Liabilities Upon Exchange For Shares Of Common Stock ReclassificationOfWarrantLiabilitiesUponExchangeForSharesOfCommonStock	0	USD
	gale	Reclassification Of Warrant Liability Upon Exercise ReclassificationOfWarrantLiabilityUponExercise	0	USD
	gale	Reclassification Of Warrant Liability Upon Exercise ReclassificationOfWarrantLiabilityUponExercise	68000	USD
	gale	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue	0	USD
	gale	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateAggregateIntrinsicValue	0	USD
CY2018Q3	gale	Stock Issued During Period Value Common Stockand Warrants StockIssuedDuringPeriodValueCommonStockandWarrants	21564000	USD
	gale	Stock Issued During Period Value Common Stockand Warrants StockIssuedDuringPeriodValueCommonStockandWarrants	21564000	USD
	gale	Stock Issued During Period Value Common Stockand Warrants StockIssuedDuringPeriodValueCommonStockandWarrants	13416000	USD
	gale	Stock Issued During Period Value New Issues Legal Settlements StockIssuedDuringPeriodValueNewIssuesLegalSettlements	1250000	USD
CY2019Q3	gale	Stock Issued During Period Value Pre Funded Warrant StockIssuedDuringPeriodValuePreFundedWarrant	3000	USD
CY2019Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	5600000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3755000	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3764000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2219000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1504000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	540000	USD
CY2019Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	328000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	87099000	USD
CY2019Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	104360000	USD
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	-4436000	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	825000	USD
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	136000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	284000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	115000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	426000	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	-5039000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	136000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	284000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	115000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	426000	USD
CY2018Q4	us-gaap	Assets Assets	16915000	USD
CY2019Q3	us-gaap	Assets Assets	21484000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	5838000	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	10211000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5337000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9100000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9119000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12750000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	91000	USD
	us-gaap	Interest Paid Net InterestPaidNet	321000	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10082000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5451000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9234000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2668000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3783000	USD
CY2017Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	371
CY2019Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	2000000	shares
CY2017Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	6323	shares
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	356000	shares
CY2019Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	302000	shares
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	531000	shares
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1250000	USD
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	440529	shares
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4549208	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	440529	shares
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4549208	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	5000	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	3587000	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2018Q3	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	8654000	USD
	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	8654000	USD
CY2019Q3	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	0	USD
	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	0	USD
CY2018Q3	us-gaap	Costs And Expenses CostsAndExpenses	3061000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	15246000	USD
CY2019Q3	us-gaap	Costs And Expenses CostsAndExpenses	4184000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	12562000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	357000	USD
CY2019Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	357000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	49000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	USD
CY2018Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	663000	USD
CY2019Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	553000	USD
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-26.75
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-137.43
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.68
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-11.37
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	675000	USD
CY2019Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	735000	USD
CY2018Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2241000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5340000	USD
CY2019Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	49000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1108000	USD
CY2018Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	766000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	766000	USD
CY2019Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018Q4	us-gaap	Goodwill Goodwill	1914000	USD
CY2019Q3	us-gaap	Goodwill Goodwill	1914000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-14347000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-11873000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	163000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4453000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-227000	USD
CY2018Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-74000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-292000	USD
CY2019Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	59000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	320000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	224000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	96000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	14000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	11670000	USD
CY2019Q3	us-gaap	Liabilities Liabilities	10847000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16915000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21484000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5974000	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5574000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23199000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17250000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-25867000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13467000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-290000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-14347000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
CY2018Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2771000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1062000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-4202000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11873000	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9435000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27928000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11470000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20532000	USD
CY2018Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-290000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14184000	USD
CY2019Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4202000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11873000	USD
CY2019Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	100000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	300000	USD
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	306000	USD
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	306000	USD
CY2019Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	306000	USD
CY2019Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.13
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	601000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	377000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	224000	USD
CY2018Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	100000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	300000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8000	USD
CY2019Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	0	USD
CY2019Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-18000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	689000	USD
CY2018Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	129000	USD
CY2019Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	44000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	134000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	487000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2018Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4436000	USD
CY2019Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	114000	USD
CY2019Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	115000	USD
CY2019Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	100000	USD
CY2019Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	13400000	USD
CY2019Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	25
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1341000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-81855000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-93728000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	550000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10130000	USD
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2385000	USD
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	387000	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	977000	USD
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	154000	USD
CY2019Q3	us-gaap	Prepaid Insurance PrepaidInsurance	479000	USD
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	166000	USD
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	87000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	21564000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13652000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	9647000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3598000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7525000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1720000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5116000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1799000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5039000	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	114000	USD
CY2019Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	115000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7523000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	284000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	426000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.8083
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.9657
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0273
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0249
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2486	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	261.22
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3264	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	18800	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	186.50
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	54.00
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7650	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	23000	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	23186	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	261.09
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	115.19
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	191.05
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	69.00
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y2M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y2M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y6M3D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y0M4D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y2M19D
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P10Y
CY2018Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-8654000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	383000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3658000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	5245000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	10637000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2070000	USD
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2483000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18457000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5245000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14338000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10637000	USD
CY2018Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	352713	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	203223	shares
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4281855	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1805773	shares

Files In Submission

Name	View Source	Status
0001390478-19-000056-index-headers.html	Edgar Link	pending
0001390478-19-000056-index.html	Edgar Link	pending
0001390478-19-000056.txt	Edgar Link	pending
0001390478-19-000056-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gale-20190930.xml	Edgar Link	completed
gale-20190930.xsd	Edgar Link	pending
gale-20190930_cal.xml	Edgar Link	unprocessable
gale-20190930_def.xml	Edgar Link	unprocessable
gale-20190930_lab.xml	Edgar Link	unprocessable
gale-20190930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sellas-logoa10.jpg	Edgar Link	pending
Show.js	Edgar Link	pending
sls-20190930x10q.htm	Edgar Link	pending
sls20190930ex103.htm	Edgar Link	pending
sls20190930ex311.htm	Edgar Link	pending
sls20190930ex312.htm	Edgar Link	pending
sls20190930ex321.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SLS
SELLAS Life Sciences Group, Inc. Stock $sls

2019 Q4 Form 10-Q Financial Statement

#000139047819000056 Filed on November 14, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SLS SELLAS Life Sciences Group, Inc. Stock $sls

2019 Q4 Form 10-Q Financial Statement

#000139047819000056 Filed on November 14, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SLS
SELLAS Life Sciences Group, Inc. Stock $sls